AHA comments on cybersecurity: Responsibility lies with device manufacturers

 

Medical device cybersecurity should be the responsibility of device makers, according to the American Hospital Association in its submitted comments on the FDA's Collaborative Approaches for Medical Device and Healthcare Cybersecurity, published in the Federal Register on Sept. 23.

The letter from AHA's Senior Vice President of Public Policy Analysis and Development Linda Fishman called on the agency to "hold device manufacturers accountable" for ensuring the safety of medical devices from cyberthreats while also encouraging them to participate in the sharing of risk information.

"Hospitals and health systems must consider the full spectrum of cyberthreats, not just those involving medical devices," Fishman wrote. "However, medical devices have been identified as key vulnerabilities and high-risk areas for the security of hospitals' overall information systems. The [healthcare and public health] sector cannot successfully protect against cyber risk unless all parts of the sector actively manage risk."

Device manufacturers, she wrote, should "embrace their responsibility to proactively minimize risk."

AHA recommends that the National Institute of Standards and Technology and "partner federal agencies make additional efforts to ensure that the guidance and standards are scalable to the smallest actors in critical infrastructure sectors, including physician offices and small rural hospitals."

Read the complete letter.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”